March 5, 2021
The FDA has issued its first emergency use authorization for a COVID-19 molecular diagnostic test that does not require a prescription and can be used at home.
Developed by Cue Health, the Cue COVID-19 Test for Home and Over the Counter Use was first authorized for point-of-care use last June.
It uses a nasal swab sample collected from the lower nose to detect the presence of SARS-CoV-2 RNA, and...
March 5, 2021
Germany is the first country in the world to prescribe digital apps – DiGAs, as the Germans call them, and reimburse them through the statutory health system as reported in Healthcare IT News.
To drive innovation and speed up the regulatory process around those digital health applications, Germany has introduced a 'Fast Track' for approval, testing, piloting and evaluation of these apps – which...
March 1, 2021
In collaboration with Affinidi, a global investment firm headquartered in Singapore, Malaysia’s Immunitee Health Passport will become the country’s first health passport allowing tourists to be accepted into Singapore upon being verified and cleared via the Affinidi’s Unifier digital credential platform. Immunitee functions as a blockchain based health passport, built on a highly secure end to...
February 26, 2021
For decades, investors, startups and a broad host of established players have viewed healthcare as ripe for innovation. However, the industry has been challenged by the momentum of the status quo – the scale, complexity, volume and ingrained practices that all need to change to wring out some much-needed efficiency.
As we were taught in physics class, the more momentum something has, the more...
February 25, 2021
Estonian UV technology company Respiray launched a wearable air purifier that the company claims can kill more almost 100% of bacteria and viruses, this week.
The device, which is worn around the neck, disinfects air coming towards the wearer through an internal filter and a germicidal UV-C light before it is ventilated towards their face.
WHY IT MATTERS
The device, which was developed with...
Credit: Laipac Technology
February 23, 2021
Two UAE-based health companies have partnered with Canada’s Laipac Technology to launch the “world’s first” artificial intelligence (AI)-powered rapid COVID-19 antigen test.
YAS Pharmaceuticals and Pure Health will be working with the Ontario-based Internet of Medical Things (IoMT) specialist to provide an “intelligent and innovative way to deploy technologies to better protect the health of...
February 18, 2021
A facelift for hospital room TVs. Amwell announced today a new tech addition to the company's hospital-focused telehealth product. Specifically, the company's Hospital TV 100 kit transforms a hospital room's existing television into a two-way video conversation with virtual providers – an approach that Amwell said will allow hospitals to leverage their existing infrastructure to scale their...
Credit: Bahrain News Agency
February 18, 2021
The Kingdom of Bahrain has become one of the first countries in the world to launch a digital COVID-19 “vaccine passport”.
According to a government press statement, the country’s BeAware app – which was launched at the onset of the pandemic to facilitate contact tracing, and currently also manages digital vaccine bookings – will function as the passport. The app will be able to confirm an...
February 17, 2021
Apple is tightening up its policy on COVID-19 vaccine passes, requiring developers to work with “entities recognized by public health authorities” before submitting to Apple. The company positioned this new policy as a way to ensure that users’ data is protected.
The tech giant notes that these new regulations come amid an increase in health passes, which are typically designed to give users...
February 16, 2021
French medication intelligence company Synapse Medicine has rolled-out its Medication Shield technology in collaboration with the regional pharmacovigilance centers (CRPVs) and the French National Agency for Medicines and Health Products Safety (ANSM).
The technology claims to increase the safety of the COVID-19 vaccination campaign in France by managing the adverse drug reactions (ADRs) signals...